In vitro and in vivo effects of a cyclic peptide with affinity for the αvβ3 integrin in human melanoma cells

European Journal of Cancer

Volumn 36, Issue 3, 2000, Pages 410-422

  Allman, R ^a   Cowburn, P ^a   Mason, M ^b  

^a VELINDRE CANCER CENTRE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anoikis; Apoptosis; Melanoma; RGD peptides; Xenografts

Indexed keywords

ANGIOGENESIS INHIBITOR; CYCLOPEPTIDE; INTEGRIN;

ANGIOGENESIS; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG TARGETING; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CALCIUM; CELL ADHESION; CELL SIZE; DNA FRAGMENTATION; EXTRACELLULAR MATRIX PROTEINS; FLOW CYTOMETRY; HUMANS; INTEGRINS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; RECEPTORS, VITRONECTIN; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033998223     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00279-8     Document Type: Article

References (30)

1. Carrel S, Rimoldi D. Melanoma associated antigens. Eur J Cancer 1993, 29A, 1903-1907.
2. Johnson JD, Rothbacher U, Sers C. The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 1993, 3, 337-340.
3. Hart IR, Birch M, Marshall JF. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Met Rev 1991, 10, 115-128.
4. Gehlsen KR, Davis GE, Sriramarao P. Integrin expression in human melanoma cells with differing invasive and metastatic properties. Clin Exp Metastasis 1992, 10, 111-120.
5. Pierschbacher MD, Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309, 30-33.
6. Hautanen ETA, Gailit J, Mann DN, Ruoslahti E. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 1989, 264, 1437-1442.
7. Gurrath M, Muller G, Kessler H, Aumailley M, Timpl R. Conformation/activity studies of rationally designed potent antiadhesive RGD peptides. Eur J Biochem 1992, 210, 911-921.
8. Pfaff M, Tangemann K, Muller B, et al. Selective recognition of cyclic RGD peptides of NMR defined conformation by αIIbβ3, αvβ3 and α5β1 integrins. J Biol Chem 1994, 269, 20233-20238.
9. Herlyn MH, Balaban G, Bennicelli J, et al. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 1985, 74, 283-289.
10. Herlyn M, Thurin J, Balaban G, et al. Characteristics of cultured human melanocytes isolated from different stages of tumour progression. Cancer Res 1985, 45, 5670-5676.
11. Montgomery AMP, Reisfeld RA, Cheresh DA. Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994, 91, 8856-8860.
12. ++ with Fluo-3. Cytometry 1990, 11, 923-927.
13. Gorczca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells in the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993, 53, 1945-1951.
14. Felding-Habermann B, Mueller BM, Romerdahl CA, Cheresh DA. Involvement of the αV gene in human melanoma tumorigenicity. J Clin Invest 1992, 89, 2018-2022.
15. Davis GE. Affinity of integrins for damaged extracellular matrix: αvβ3 binds to denatured collagen type 1 through RGD sites. Biochem Biophys Res Commun 1992, 182, 1025-1031.
16. Ruoslahti E, Reed J. Anchorage dependence, integrins and apoptosis. Cell 1994, 77, 477-478.
17. Brooks PC, Montgomery AMP, Rosenfeld M, et al. Integrin αvβ3 antagonists promote tumour regression by inducing apoptosis of angiogenic blood vessels. Cell 1994, 79, 1157-1164.
18. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarker FH, Cheresh DA. Anti-integrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995, 96, 1815-1822.
19. Hammes HP, Brownlee M, Joncyk A, Sutler A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularisation. Nature Med 1996, 2, 529-533.
20. Buckley CD, Pilling D, Henriquez NV, et al. RGD peptides induce apoptosis by direct caspase-3 activation. Nature 1999, 397, 534-539.
21. Kumagai H, Tajima M, Ueno Y, Giga-hama Y, Ohba M. Effect of cyclic RGD peptide on cell adhesion and tumour metastasis. Biochem Biophys Res Commun 1991, 177, 74-82.
22. Kawahara E, Imai K, Kumagai S, Yamamoto E, Nakanishi I. Inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells with special reference to implication of alpha v integrins. J Cancer Res Clin Oncol 1995, 121, 133-140.
23. Park RH, Yun I. Role of VLA-integrin receptor in invasion and metastasis of human fibrosarcoma cells. Cancer Letts 1996, 106, 227-233.
24. Foster MR, Hornly EJ, Brown S, Kitchin J, Hann M, Ward P. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs. Thrombosis Res 1993, 72, 231-245.
25. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978, 273, 345-349.
26. Meredith JE, Fazeli B, Schwartz MA. The extracellular matrix as a cell survival factor. Mol Biol Cell 1993, 4, 953-961.
27. Frisch SM, Francis H. Disruption of epithelial cell-matrix interaction induces apoptosis. J Cell Biol 1994, 24, 619-626.
28. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The α5β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995, 92, 6161-6165.
29. WAF1/CIP1 expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 1996, 98, 426-433.
30. Friedlander M, Theesfeld CL, Sugita M, et al. Involvement of integrins αvβ3 and αvβ5 in ocular neovascular disease. Proc Natl Acad Sci USA 1996, 93, 9764-9769.